lzyq88¹ÙÍø

ÀÏ×ÓÓÐÇ®lzyq88(Öйú)ÓÐÏÞ¹«Ë¾¹ÙÍø
media center

´«Ã½ÖÐÐÄ

ʱ¿ÌÓëÄú·ÖÏílzyq88¹ÙÍøÒ»µãÒ»µÎ
  • 2020-08-18

    ΢´´?Ò½ÁÆ£¨00853.HK£©»ñÄÉÈëMSCIÏã¸ÛÖ¸Êý

    Öйú£¬ £¬£¬£¬£¬£¬£¬ÉϺ£——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬È«ÇòÖøÃûµÄÖ¸ÊýÌåÀý¹«Ë¾MSCIÃ÷êÉÐû²¼ÁË×îм¾¶ÈÖ¸Êýµ÷½âЧ¹û£¬ £¬£¬£¬£¬£¬£¬Î¢´´Ò½ÁÆ¿ÆÑ§ÓÐÏÞ¹«Ë¾£¨00853.HK£©ÓÉMSCIÏã¸ÛСÐ͹ÉÖ¸ÊýÒòËØ¹ÉתΪMSCIÏã¸ÛÖ¸ÊýÒòËØ¹É£¬ £¬£¬£¬£¬£¬£¬ÉÏÊö±ä»»½«ÓÚ2020Äê8ÔÂ31ÈÕÊÕÊкóÉúЧ¡£¡£¡£¡£¡£¡£¡£   MSCIÃ÷êÉÊÇÏÖÔÚÈ«ÇòÓ°ÏìÁ¦×î´óµÄÖ¸ÊýÌṩÉÌÖ®Ò»£¬ £¬£¬£¬£¬£¬£¬ÆäÌåÀýµÄÖ¸Êý¹ãΪͶ×ÊÈ˲ο¼£¬ £¬£¬£¬£¬£¬£¬Êǹú¼ÊͶ×ʵē·çÏò±ê”£¬ £¬£¬£¬£¬£¬£¬MSC
  • 2020-08-18

    ΢´´?Éñͨ¾ÙÐÐTWINSÔÆ¶ËרÌâ»á

    Öйú£¬ £¬£¬£¬£¬£¬£¬ÉϺ£——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬Î¢´´ÉñͨҽÁƿƼ¼£¨ÉϺ££©ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®Éñͨ”£©ÔÚÏßÉϾÙÐÐÁËTWINSÔÆ¶ËרÌâ×ù̸»á£¬ £¬£¬£¬£¬£¬£¬±¾´ÎÔ˶¯Ô¼Çë¶àλÉñ¾­½éÈëÁìÓòר¼Ò£¬ £¬£¬£¬£¬£¬£¬Î§ÈÆ“¸²Ä¤Ö§¼ÜÓëѪÁ÷µ¼Ïò×°ÖõÄÖÎÁƼƻ®Ñ¡Ôñ”¾ÙÐÐ̽ÌÖ£¬ £¬£¬£¬£¬£¬£¬·ÖÏí­ÄÚ¶¯ÂöÁöÖÎÁÆ×îÇ°ÑØµÄÊÖÒÕ£¬ £¬£¬£¬£¬£¬£¬½»Á÷ʹÓø²Ä¤Ö§¼ÜÓëѪ¹ÜÖØÐÞ×°ÖõÄÁÙ´²ÂÄÀúºÍ˼Ë÷¡£¡£¡£¡£¡£¡£¡£   ÉϺ£³¤º£Ò½ÔºÁõ½¨
  • 2020-08-17

    ÐÄÂöÒ½ÁÆ?Minos?¸²Ä¤Ö§¼ÜϵͳÔÚÒâ´óÀûÍê³ÉÊ×ÀýÁÙ´²Ö²Èë

    Òâ´óÀû£¬ £¬£¬£¬£¬£¬£¬°ÍÈøÅµ——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“ÐÄÂöÒ½ÁÆ™”£©µÄMinos®¸¹×Ô¶¯Âö¸²Ä¤Ö§¼Ü¼°ÔËËÍϵͳ£¨ÒÔϼò³Æ“Minos®¸²Ä¤Ö§¼Üϵͳ”£©ÔÚÒâ´óÀû˳ËìÍê³ÉÊ×ÀýÁÙ´²Ö²Èë¡£¡£¡£¡£¡£¡£¡£ÕâÊǼÌÏ£À°¡¢²¨À¼¡¢Î÷°àÑÀ¼°µÂ¹úÖ®ºó£¬ £¬£¬£¬£¬£¬£¬Minos®¸²Ä¤Ö§¼Üϵͳ½øÈëµÄµÚÎå¸öÍâÑóÊг¡¡£¡£¡£¡£¡£¡£¡£ &nb
  • 2020-08-16

    ΢´´?ÆìÏÂ4¼Ò¹«Ë¾»ñÆÀ¡°2020ÄêÉϺ£ÊÐרÀûÊÂÇéÊÔµãÊ÷Ä£ÆóÒµ¡±

    Öйú£¬ £¬£¬£¬£¬£¬£¬ÉϺ£——½üÆÚ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£ÊÐ֪ʶ²úȨ¾ÖÐû²¼ÁË“2020ÄêÄâÈ϶¨ÉϺ£ÊÐרÀûÊÂÇéÊÔµãÊ÷Ä£µ¥Î»”Ãûµ¥£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´Ò½ÁÆÆ÷е£¨¼¯ÍÅ£©ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®”£©ÆìÏ»òÏà¹Ø¹«Ë¾Öй²ÓÐ4¼ÒÆóÒµ°ñÉÏÖøÃû¡£¡£¡£¡£¡£¡£¡£ÆäÖУ¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´µçÐÄÀíÒ½ÁƿƼ¼¹É·ÝÓÐÏÞ¹«Ë¾¼°ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾»ñµÃ“ÉϺ£ÊÐרÀûÊÂÇéÊ÷Ä£ÆóÒµ&rdquo
  • 2020-08-10

    ΢´´?ÐÄͨVitaFlow?¾­µ¼¹Ü×Ô¶¯Âö°êĤϵͳÔÚ°¢¸ùÍ¢»ñÅúÉÏÊÐ

    Öйú£¬ £¬£¬£¬£¬£¬£¬ÉϺ£——2020Äê7ÔÂ27ÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´ÐÄͨҽÁƿƼ¼ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®ÐÄͨ”£©×ÔÖ÷Ñз¢µÄVitaFlow®¾­µ¼¹Ü×Ô¶¯Âö°êĤϵͳ£¨“VitaFlow®°êĤϵͳ”£©£¬ £¬£¬£¬£¬£¬£¬°½¹ã™£¨Alwide™£©°êĤÇòÄÒÀ©Õŵ¼¹ÜºÍ°½Ë³™£¨Alpass™£©µ¼¹ÜÇÊÌ×¼þ»ñµÃ°¢
  • 2020-08-08

    ÐÄÂöÒ½ÁÆ?Hercules?-LPÖ§¼ÜϵͳºÍMinos?¸²Ä¤Ö§¼ÜϵͳÔڵ¹úÍê³ÉÊ×ÀýÁÙ´²Ö²Èë

    µÂ¹ú£¬ £¬£¬£¬£¬£¬£¬»ôÄ·±¤&¸¥À³±¤——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“ÐÄÂöÒ½ÁÆ™”£©µÄHercules® Low ProfileÖ±¹ÜÐ͸²Ä¤Ö§¼Ü¼°ÔËËÍϵͳ£¨ÒÔϼò³Æ“Hercules®-LPÖ§¼Üϵͳ”£©ºÍMinos®¸¹×Ô¶¯Âö¸²Ä¤Ö§¼Ü¼°ÔËËÍϵͳ£¨ÒÔϼò³Æ“Mino
  • 2020-08-07

    ΢´´?ÁúÂöѪ¹ÜÔìÓ°µ¼Ë¿ºÍѪ¹ÜÔìÓ°µ¼¹ÜÔÚ°ÍÎ÷»ñÅúÉÏÊÐ

    °ÍÎ÷£¬ £¬£¬£¬£¬£¬£¬°ÍÎ÷ÀûÑÇ——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´ÁúÂöÒ½ÁÆÆ÷²ÄÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®ÁúÂö”£©Ñз¢µÄѪ¹ÜÔìÓ°µ¼Ë¿ºÍѪ¹ÜÔìÓ°µ¼¹Ü»ñµÃ°ÍÎ÷ÎÀÉú¼àÊÓÖÎÀí¾Ö£¨Brazil ANVISA£©×¢²áÅú×¼¡£¡£¡£¡£¡£¡£¡£   ¾­Æ¤¹Ú×´¶¯Âö½éÈëÖÎÁÆ£¨PCI£©Êǵ±½ñ¹ÚÐIJ¡Õï¶ÏºÍÖÎÁƵÄÖ÷ÒªÊֶΣ¬ £¬£¬£¬£¬£¬£¬Ñª¹ÜÔìÓ°µ¼Ë¿ºÍѪ¹ÜÔìÓ°µ¼¹ÜÊÇPCIÊÖÊõÖеÄÖ÷ÒªÆ÷е֮һ¡£¡£¡£¡£¡£¡£¡£½ÓÄɾ­Æ¤´©´ÌÊÖÒտɽ«Ñª¹ÜÔìÓ°µ¼Ë¿
  • 2020-08-06

    ΢´´?µçÐÄÀíÒýÈëеÄÕ½ÂÔͶ×ÊÕß

    ΢´´®µçÐÄÀíÒýÈëÁËÖÐÐŹ¤Òµ»ù½ð¡¢Ô¶ÒíͶ×Ê¡¢Ò×·½´ï×ÊÔ´¡¢ÆÖ¶«¿Æ´´¼¯ÍÅËļÒ×ÅÃûÕ½ÂÔͶ×ÊÕߣ¬ £¬£¬£¬£¬£¬£¬Íê³É3ÒÚÔªÈËÃñ±ÒÈÚ×ÊЭÒéµÄÕýʽǩÊ𠽫Ϊ¹«Ë¾µÄвúÆ·¿ª·¢ºÍÊг¡¿ªÍØ´øÀ´ÐëÒªµÄ×ʽðÖ§³Ö£¬ £¬£¬£¬£¬£¬£¬ÖúÁ¦Î¢´´®µçÐÄÀíÓªÒµ½øÈë¿ìËÙÉú³¤µÄн׶Π  Öйú£¬ £¬£¬£¬£¬£¬£¬ÉϺ£——2020Äê8ÔÂ5ÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´µçÐÄÀíÒ½ÁƿƼ¼¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®µçÐÄÀí&rdq
  • 2020-08-05

    2020ÄêµÚ6ÆÚ ×ܵÚ136ÆÚ

  • 2020-08-05

    ΢´´?ÁúÂöPCIÅä¼þÔÚ°£¼°»ñÅúÉÏÊУ¬ £¬£¬£¬£¬£¬£¬Ê׶ȽøÈë·ÇÖÞ¹ú¼Ò

    °£¼°£¬ £¬£¬£¬£¬£¬£¬¿ªÂÞ——¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÉϺ£Î¢´´ÁúÂöÒ½ÁÆÆ÷²ÄÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®ÁúÂö”£©ÆìÏÂÁúÂöÒ½ÁÆÆ÷е£¨±±¾©£©ÓÐÏÞ¹«Ë¾µÄѹÁ¦±Ã¡¢Ö¸»·ÍÆ×¢Æ÷¡¢Á¬Í¨°å¡¢YÐÍÅþÁ¬Æ÷×é¼þµÈ¶à¿îPCIÅä¼þ»ñµÃ°£¼°Ö÷¹ÜÕþ¸®£¨Central Administration for Pharmaceutical Affairs£¬ £¬£¬£¬£¬£¬£¬CAPA£©µÄ×¢²áÅú×¼¡£¡£¡£¡£¡£¡£¡£ÕâÊÇ΢´´®ÁúÂöµÄÅä¼þ²úÆ·Ê×´ÎÔÚ
×Ü¼Æ 2367 12...90919293949596...236237
ÀÏ×ÓÓÐÇ®lzyq88(Öйú)ÓÐÏÞ¹«Ë¾¹ÙÍø
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿